BMJ 2000;320:1007 ( 8 April )

Letters

Intention to treat analysis is related to methodological quality

EDITOR---In their survey of all randomised controlled trials published in 1997 in four major medical journals, Hollis and Campbell found that only 48% of the reports explicitly mentioned intention to treat analysis.1 In a considerable proportion it was insufficiently described and sometimes inadequately applied. Their results are confirmed by our assessment of all randomised controlled trials published between 1993 and 1995 in the same four journals.2 In addition to our assessment of ethical issues, we calculated the proportion of randomised controlled trials reporting intention to treat analysis in accordance with different descriptive and methodological characteristics.

In our review of 608 randomised controlled trials, we found that 290 of the trials (47.7%) explicitly mentioned that they applied the principle of intention to treat analysis. The reporting of this issue increased slightly between 1993 and 1995 (although the increase was not significant). Trials with a greater number of participants and those funded by the pharmaceutical industry were more likely to report the application of the intention to treat principle (table). In the multivariable logistic regression analysis, when we controlled for the general characteristics previously described, we found that trials with survival of patients as the principal outcome were more frequently reported to follow the intention to treat principle. In addition, those randomised controlled trials that gave no information about sample size were less likely to report the use of this principle (table). Randomised controlled trials not reporting the number of withdrawals or losses to follow up and those not reporting information about compliance with treatment were also less likely to report the intention to treat principle, although these results were not significant.


                              
View this table:
[in this window]
[in a new window]
 

Reporting of intention to treat analysis in published clinical trials (1993-5)

Our data support the relation between a higher methodological quality of the trials and the reporting of the intention to treat analysis. Our results reinforce the conclusions of Hollis and Campbell that the application of this principle still needs to improve because it seems that there has been no improvement between 1993 and 1997.1 A joint effort of editors and researchers is needed to meet the CONSORT guidelines3 and the authors' recommendations favouring intention to treat analysis.1 A better quality of reporting will help readers to assess the design, conduct, and analysis of randomised controlled trials more critically.

Miguel Ruiz-Canela, assistant professor
Department of Biomedical Humanities and Department of Epidemiology and Public Health, School of Medicine, University of Navarra, E 31080 Pamplona, Spain mcanela{at}unav.es

Miguel Angel Martínez-González, acting chair
Jokin de Irala-Estévez, associate professor
Department of Epidemiology and Public Health, School of Medicine, University of Navarra



1. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319: 670-674[Abstract/Free Full Text]. (11 November.)
2. Ruiz-Canela M, Martínez-González MA, Gómez Gracia E, Fernández-Crehuet Navajas J. Informed consent and approval by institutional review board in published clinical trials. N Engl J Med 1999; 340: 1114-1115[Free Full Text]. (Erratum N Engl J Med 1999;341:460.)
3. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276: 637-639[CrossRef][Medline].


© BMJ 2000

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

What is meant by intention to treat analysis? Survey of published randomised controlled trials
Sally Hollis and Fiona Campbell
BMJ 1999 319: 670-674. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Olivo, S. A., Macedo, L. G., Gadotti, I. C., Fuentes, J., Stanton, T., Magee, D. J (2008). Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review. ptjournal 88: 156-175 [Abstract] [Full text]  
  • Gravel, J., Opatrny, L., Shapiro, S. (2007). The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?. Clin Trials 4: 350-356 [Abstract]  
  • Whittaker, K., Sutton, C., Burton, C. (2006). Pragmatic randomised controlled trials in parenting research: the issue of intention to treat.. J. Epidemiol. Community Health 60: 858-864 [Abstract] [Full text]  
  • SAUERLAND, S., DAVIS, T. R. C. (2004). The Consolidated Standards of Reporting Trials (CONSORT): Better Presentation of Surgical Trials in the Journal of Hand Surgery. J Hand Surg Eur Vol 29: 621-624 [Abstract] [Full text]  
  • Montori, V. M., Guyatt, G. H. (2001). Intention-to-treat principle. CMAJ 165: 1339-1341 [Full text]  
  • Moher, D., Schulz, K. F., Altman, D. G. (2001). The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. J. Am. Podiatr. Med. Assoc. 91: 437-442 [Abstract] [Full text]  
  • Ruiz-Canela, M., de Irala-Estevez, J., Martinez-Gonzalez, M. A., Gomez-Gracia, E., Fernandez-Crehuet, J. (2001). Methodological quality and reporting of ethical requirements in clinical trials. J. Med. Ethics 27: 172-176 [Abstract] [Full text]  
  • Moher, D., Schulz, K. F., Altman, D., for the CONSORT Group, (2001). The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. JAMA 285: 1987-1991 [Abstract] [Full text]  



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview